newsfilter
← Latest News
GlobeNewswire·

Ashland reports second quarter fiscal 2025 results and revises full-year outlook

Sales of $479 million, down 17 percent from the prior-year quarterPreviously announced carboxymethylcellulose (CMC), methylcellulose (MC), nutraceuticals and Avoca portfolio optimization initiatives (collectively,